In this context, two independent studies investigated the therapeutic effects of astrocyte-derived PDGF-A by conditional overexpression in mouse models of chronic and acute CNS demyelination and revealed that elevated expression of PDGF-A by astrocytes significantly increased OPC survival and population density (87, 88) (Figure 2). The gene discussed is PDGFA; the disease is Peripheral demyelination.